Family Medicine · Ciales, PR
NPI
1740238609
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
Carr. 146 Km 27.4, Bo. Cordilleras
Ciales, PR, 00638
Phone (787) 871-3919
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$880K
18,999 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Carlos M Otero Rivera I prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,013 prescriptions and refills. In total Carlos M Otero Rivera I wrote 18,999 Medicare prescriptions that cost $880K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-11.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Rosuvastatin Calcium Generic | 1,013 | 1,267 | 165 | $6,476 |
| Losartan Potassium Generic | 965 | 1,289 | 146 | $7,118 |
| Gabapentin Generic | 789 | 955 | 164 | $7,329 |
| Synthroid Levothyroxine Sodium | 548 | 665 | 75 | $32K |
| Famotidine Generic | 533 | 574 | 99 | $3,323 |
| Atorvastatin Calcium Generic | 512 | 678 | 99 | $3,209 |
| Clonazepam Generic | 477 | 477 | 73 | $4,253 |
| Omeprazole Generic | 460 | 508 | 91 | $2,301 |
| Tramadol Hcl Generic | 381 | 381 | 81 | $2,503 |
| Metformin Hcl Generic | 359 | 545 | 67 | $1,697 |
| Amlodipine Besylate Generic | 346 | 481 | 65 | $1,225 |
| Metoprolol Succinate Generic | 303 | 391 | 50 | $2,743 |
| Tamsulosin Hcl Generic | 286 | 374 | 56 | $2,093 |
| Lisinopril Generic | 268 | 366 | 39 | $1,065 |
| Ezetimibe Generic | 249 | 325 | 44 | $2,566 |
Brand drugs: 2,354 claims; generic drugs: 16,512 claims; opioid claims: 473.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Carlos M Otero Rivera I were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.